Literature DB >> 2405014

Antibiotic resistance patterns of group B streptococci in pregnant women.

K Berkowitz1, J A Regan, E Greenberg.   

Abstract

This study examined the antibiotic resistance patterns of group B streptococci (GBS) isolated from gravid women. A total of 156 vaginal and cervical isolates of GBS were examined for resistance to penicillin, ampicillin, clindamycin, cefoxitin, gentamicin, and erythromicin. No resistance to penicillin or ampicillin was found, nor was penicillinase production demonstrated. A high level of resistance to gentamicin was noted (91%). Of the isolates examined, 9, 9.5, and 15.3% exhibited either resistance or intermediate susceptibility to erythromycin, clindamycin, and cefoxitin, respectively. Thirty strains (19%) exhibited a multiple antibiotic resistance pattern. Given the high penicillin and ampicillin treatment failure rates when attempting to eradicate vaginal GBS colonization and our findings of higher and multiple drug resistance patterns of GBS, the selection of an alternative antibiotic regimen is of considerable clinical importance. We recommend that routine reporting of GBS susceptibilities by clinical laboratories be adopted.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2405014      PMCID: PMC269526          DOI: 10.1128/jcm.28.1.5-7.1990

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  17 in total

1.  Antimicrobial susceptibility of group B streptococci isolated from a variety of clinical sources.

Authors:  C J Baker; B J Webb; F F Barrett
Journal:  Antimicrob Agents Chemother       Date:  1976-07       Impact factor: 5.191

2.  Plasmids mediating multiple drug resistance in group B streptococcus: transferability and molecular properties.

Authors:  V Hershfield
Journal:  Plasmid       Date:  1979-01       Impact factor: 3.466

3.  Selective broth medium for isolation of group B streptococci.

Authors:  C J Baker; D J Clark; F F Barrett
Journal:  Appl Microbiol       Date:  1973-12

4.  pH-dependent penicillin tolerance of group B streptococci.

Authors:  D Horne; A Tomasz
Journal:  Antimicrob Agents Chemother       Date:  1981-07       Impact factor: 5.191

5.  Premature rupture of membranes, preterm delivery, and group B streptococcal colonization of mothers.

Authors:  J A Regan; S Chao; L S James
Journal:  Am J Obstet Gynecol       Date:  1981-09-15       Impact factor: 8.661

6.  Laboratory and field evaluation of selective media for isolation of group B streptococci.

Authors:  B M Gray; M A Pass; H C Dillon
Journal:  J Clin Microbiol       Date:  1979-04       Impact factor: 5.948

7.  Group B beta-hemolytic streptococcus: randomized controlled treatment study at term.

Authors:  G B Merenstein; W A Todd; G Brown; C C Yost; T Luzier
Journal:  Obstet Gynecol       Date:  1980-03       Impact factor: 7.661

8.  Ampicillin prevents intrapartum transmission of group B streptococcus.

Authors:  M D Yow; E O Mason; L J Leeds; P K Thompson; D J Clark; S E Gardner
Journal:  JAMA       Date:  1979-03-23       Impact factor: 56.272

9.  Failure of penicillin to eradicate group B streptococcal colonization in the pregnant woman. A couple study.

Authors:  S E Gardner; M D Yow; L J Leeds; P K Thompson; E O Mason; D J Clark
Journal:  Am J Obstet Gynecol       Date:  1979-12-15       Impact factor: 8.661

10.  Penicillin tolerance in group B streptococci isolated from infected neonates.

Authors:  K S Kim; B F Anthony
Journal:  J Infect Dis       Date:  1981-11       Impact factor: 5.226

View more
  18 in total

1.  Antibiotic susceptibility and mechanisms of erythromycin resistance in clinical isolates of Streptococcus agalactiae: French multicenter study.

Authors:  D De Mouy; J D Cavallo; R Leclercq; R Fabre
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

2.  High incidence of erythromycin resistance among clinical isolates of Streptococcus agalactiae in Taiwan.

Authors:  P R Hsueh; L J Teng; L N Lee; S W Ho; P C Yang; K T Luh
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

3.  Prevention of group B streptococcal infection in newborns: recommendation statement from the Canadian Task Force on Preventive Health Care.

Authors: 
Journal:  CMAJ       Date:  2002-04-02       Impact factor: 8.262

4.  Prevention of group B streptococcal infection in newborns. Recommendation statement from the Canadian Task Force on Preventive Health Care.

Authors: 
Journal:  Can Fam Physician       Date:  2002-05       Impact factor: 3.275

5.  Antimicrobial susceptibilities of group B streptococci isolated between 1992 and 1996 from patients with bacteremia or meningitis.

Authors:  M Fernandez; M E Hickman; C J Baker
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

6.  Colonization rates and serotypes of group B streptococci isolated from pregnant women in a Korean tertiary hospital.

Authors:  Y Uh; I H Jang; K J Yoon; C H Lee; J Y Kwon; M C Kim
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-10       Impact factor: 3.267

7.  Ampicillin susceptibilities of vaginal and placental isolates of group B streptococcus and Escherichia coli obtained between 1992 and 1994.

Authors:  L A Meyn; S L Hillier
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

8.  Antibiotic resistance and penicillin tolerance in clinical isolates of group B streptococci.

Authors:  C Betriu; M Gomez; A Sanchez; A Cruceyra; J Romero; J J Picazo
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

9.  Resistance of group B streptococcus to selected antibiotics, including erythromycin and clindamycin.

Authors:  Judith S Heelan; Meredith E Hasenbein; Alexander J McAdam
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

10.  In vivo efficacy of azithromycin in treatment of systemic infection and septic arthritis induced by type IV group B Streptococcus strains in mice: comparative study with erythromycin and penicillin G.

Authors:  L Tissi; C von Hunolstein; P Mosci; C Campanelli; F Bistoni; G Orefici
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.